作者: Michel Koole , Kathleen Vunckx , Jeroen Verhaeghe , Koen Van Laere , Peter Jan Van Laar
DOI: 10.1007/978-3-642-54307-4_5
关键词: Neuroimaging 、 In vivo magnetic resonance spectroscopy 、 Neuroscience 、 Dynamic contrast-enhanced MRI 、 Disease progression 、 Medicine 、 Positron emission tomography 、 Pet imaging 、 Brain morphometry 、 Magnetic resonance imaging
摘要: Multimodalbrain imaging has become an established clinical and research tool for diagnosis disease progression of brain disorders. Among available modalities, magnetic resonance (MRI) positron emission tomography (PET) can provide a wide spectrum data the in vivo mapping neurobiological functions morphology while demonstrating to relationships between behavioral factors. Since MRI mostly uses endogenous contrast mechanisms visualize quantify tissue characteristics, optimal sequence design is essential diagnostic information MRI. On other hand, PET always based on exogenous injected tracer. Therefore, characteristics tracer determine quantitative potential PET. This chapter will focus both these modalities shortly discuss multimodal or hybrid MR/PET imaging. We not cover MR spectroscopy nor specific applications H2 15O since this be discussed chapters book.